MAPK1 and renal cell carcinoma: Overexpression of Ras protein activator like 2 (RASAL2) upregulates SOX2 expression, inhibits the activity of ERK and p38 MAPK signaling pathways, and inhibits RCC cell invasion (Wang S. et al., 2020).